Dean P. Stull, Ph.D. - President and CEO
Dr. Stull, an entrepreneur in the development of active pharmaceutical ingredients (APIs), dietary supplement ingredients (NDIs) and flavor ingredients derived from botanicals, was the founder and Principal of Innovation Science, which provides consulting services for biotechnology, medical food and specialized functional food companies. He currently serves as Chairman of the Board of Pyxant Laboratories, which provides bioanalytical services for preclinical and clinical development programs. Previously, Dr. Stull served as Chief Scientific Officer of medical foods company Efficas and was President and founder of InB: Hauser Pharmaceutical Services and InB: Paxis Pharmaceuticals. Earlier, Dr. Stull was a founder and served as CEO, Chairman and President of Hauser, Inc. a Nasdaq-listed public company that was the first commercial supplier of paclitaxel, the active ingredient in Taxol®. He received a B.S. degree from Colorado State University and M.S. and Ph.D. degrees from the University of Colorado at Boulder.
Mark Heiman, Ph.D. - Vice President of Research & Chief Scientific Officer
Dr. Heiman is a leading academic and industrial researcher in endocrinology and obesity. Prior to joining NuMe Health, he worked at Eli Lilly for more than 20 years, where he held positions of increasing responsibility in endocrine-related drug discovery and development. Most recently, Dr. Heiman served as Chief Scientific Officer of the obesity drug discovery team and as a research fellow in the Division of Endocrinology. Dr. Heiman has co-authored 90 scientific publications and helped develop 30 drug-related patents. He received a B.A. from the University of New Orleans, a Ph.D. from Louisiana State University School of Medicine and completed a post doctoral research fellowship at Indiana University School of Medicine.